OpenResearchAlpha

Psychotherapy and Psychosomatics · 13 Nov 2026

Guided self-help for depression adapted for autistic adults: a multi-centre randomised controlled phase 3 trial (ADEPT-2)

Ailsa Russell, Maximiliano Vazquez-Morales, Kate Cooper, Dave Dagnan, Peter E Langdon, Chris Metcalfe, Jeremy Horwood, Barry Ingham, Dheeraj Rai, Joanna Thorn, Nicola Wiles, David Kessler, Leonora Cotton, Aikaterini Georgakopoulou, Alba X Realpe, Kirsty Garfield, Mannat Chopra, Rona Aldridge, Alison Cape, Vicky Jervis

0
Citations
no database records one yet
0
Citations in 2026
so far
–
Leading author's h-index
no author has a profile yet
0
References
works it cites, from open citation data

Citations by database

Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.

  • OpenCitations0
  • Crossref0
  • Europe PMC0

Citations per year

The current year is still counting.

  • 2026 so far0

Abstract

Abstract Introduction Autistic people are disproportionately affected by depression and access recommended first line treatments such as Guided Self-Help (GSH)) which has not been developed to meet their needs. This study aims to test the effectiveness of autism adapted GSH for depression compared to treatment as usual. Methods A two parallel group multi-centre randomised controlled trial investigated the effectiveness of GSH adapted for autism. The RCT was registered on 09th August 2022 (ISRCTN: 17547011). Adults, ≥18 years, with a confirmed autism diagnosis and symptoms of depression (PHQ-9 ≥ 10) recruited from community settings were randomised to GSH or Treatment as Usual (TAU). Adapted GSH comprised psychoeducation and behavioural activation supported by nine meetings with a coach. Beck Depression Inventory (BDI-II) scores at 16-weeks post-randomisation were analysed on an intention to treat basis. Additional measures at 16-weeks captured anxiety, well-being and service use with follow up at 32- and 52-weeks. Results Participants (n=266) were randomised to GSH (n=132) or TAU (n=134). Of participants randomised to GSH, 110 (81%) completed the minimum 6 session dose, five did not begin the intervention and 28 discontinued. Estimated between group mean difference in BDI-II scores at 16 weeks was -5.05 (95% CI: -7.85 to -2.24, P<0.001, d=0.47) in favour of GSH, with the difference sustained at 52-weeks. Conclusion The intervention named Autism Affirming Accompanied Self-Help for depression (AASH-DEP) needs to be rolled-out so clinicians and autistic people can be confident to access effective treatment for depression adapted for autism.

What the data shows

  • No database records a citation yet, as is usual for a paper this new.

Graph

This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.

Citing paper shares an authorAuthor without a profileSize shows citations, or h-index for authors

Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.

Start with

Authors (20)

Each author's standing in QAI's scholar index: the works their ORCID iD is attached to, and for anyone whose ORCID record names a lab OpenResearch follows, their arXiv preprints matched by name and a shared co-author. Names are as printed on the paper.

ProfileMost-cited paper

Cited by 0 papers

Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.

0 shown
No citing papers for this filter.

References (0)

What it cites, from open citation data, with Crossref's record of each.

No references in the open citation data yet.